cognitive cybersecurity intelligence
Subscribe to HEAL Security Dispatch for the latest healthcare cybersecurity news and analysis.
This week in cybersecurity serves as a critical reminder of the pervasive risks within the digital supply chain, as several industry-leading companies disclosed significant data
With positive Phase 1 results for the metabolic disorder drug MZE782, Maze Therapeutics plans to advance the small molecule to Phase 2 tests in phenylketonuria
Healthcare groups are pushing back on CMS’ proposed physician fee schedule for next year, raising concerns over payment cuts, administrative burdens and mandatory participation in
SECURITY AFFAIRS MALWARE NEWSLETTER ROUND 62 Security Affairs
